105 related articles for article (PubMed ID: 33462702)
1. The Value of Navigators in Breast Cancer Management in a South African Hospital.
Čačala SR; Farrow H; Makhanya S; Couch DG; Joffe M; Stopforth L
World J Surg; 2021 May; 45(5):1316-1322. PubMed ID: 33462702
[TBL] [Abstract][Full Text] [Related]
2. Neoadjuvant Chemotherapy Use for Nonmetastatic Breast Cancer at Five Public South African Hospitals and Impact on Time to Initial Cancer Therapy.
O'Neil DS; Nietz S; Buccimazza I; Singh U; Čačala S; Stopforth LW; Joffe M; Jacobson JS; Neugut AI; Crew KD; Ruff P; Cubasch H
Oncologist; 2019 Jul; 24(7):933-944. PubMed ID: 30518615
[TBL] [Abstract][Full Text] [Related]
3. Early post-operative removal of urethral catheter in patients undergoing colorectal surgery with epidural analgesia – a prospective pilot clinical study.
Coyle D; Joyce KM; Garvin JT; Regan M; McAnena OJ; Neary PM; Joyce MR
Int J Surg; 2015 Apr; 16(Pt A):94-98. PubMed ID: 25769395
[TBL] [Abstract][Full Text] [Related]
4. Psychosis brain subtypes validated in first-episode cohorts and related to illness remission: results from the PHENOM consortium.
Dwyer DB; Chand GB; Pigoni A; Khuntia A; Wen J; Antoniades M; Hwang G; Erus G; Doshi J; Srinivasan D; Varol E; Kahn RS; Schnack HG; Meisenzahl E; Wood SJ; Zhuo C; Sotiras A; Shinohara RT; Shou H; Fan Y; Schaulfelberger M; Rosa P; Lalousis PA; Upthegrove R; Kaczkurkin AN; Moore TM; Nelson B; Gur RE; Gur RC; Ritchie MD; Satterthwaite TD; Murray RM; Di Forti M; Ciufolini S; Zanetti MV; Wolf DH; Pantelis C; Crespo-Facorro B; Busatto GF; Davatzikos C; Koutsouleris N; Dazzan P
Mol Psychiatry; 2023 May; 28(5):2008-2017. PubMed ID: 37147389
[TBL] [Abstract][Full Text] [Related]
5. Variation in use of neoadjuvant chemotherapy in patients with stage III breast cancer: Results of the Dutch national breast cancer audit.
Spronk PER; van Bommel ACM; Siesling S; Wouters MWJM; Vrancken Peeters MTFD; Smorenburg CH
Breast; 2017 Dec; 36():34-38. PubMed ID: 28942098
[TBL] [Abstract][Full Text] [Related]
6. Effect of VEGF-C siRNA and endostatin on ring formation and proliferation of esophageal squamous cell carcinoma lymphatic endothelial cells.
Zheng Y; Sun M; Chen J; He L; Zhao N; Chen K
Onco Targets Ther; 2016; 9():6727-6732. PubMed ID: 27826199
[TBL] [Abstract][Full Text] [Related]
7. Effect of recombinant porcine somatotropin on energy and protein utilization by growing pigs: interaction with capacity for lean tissue growth.
Noblet J; Herpin P; Dubois S
J Anim Sci; 1992 Aug; 70(8):2471-84. PubMed ID: 1324236
[TBL] [Abstract][Full Text] [Related]
8. Liver structural transformation after partial hepatectomy and repeated partial hepatectomy in rats: A renewed view on liver regeneration.
Tsomaia K; Patarashvili L; Karumidze N; Bebiashvili I; Azmaipharashvili E; Modebadze I; Dzidziguri D; Sareli M; Gusev S; Kordzaia D
World J Gastroenterol; 2020 Jul; 26(27):3899-3916. PubMed ID: 32774065
[TBL] [Abstract][Full Text] [Related]
9. Development of a method to determine the cost of breast cancer treatment with chemotherapy at Groote Schuur Hospital, Cape Town, South Africa.
Guzha NT; Thebe T; Butler N; Valodia PN
S Afr Med J; 2020 Mar; 110(4):296-301. PubMed ID: 32657741
[TBL] [Abstract][Full Text] [Related]
10. [The effect of basic therapy with calcium and vitamins D3 and B6 on muscle strength, movement and balance functions at patients with osteoporosis undergoing medical rehabilitation].
Marchenkova LA; Makarova EV; Vasilieva VA; Eryomushkin MA; Styazhkina EM; Razvalyayeva DV; Chesnikova EI; Gerasimenko MY
Vopr Kurortol Fizioter Lech Fiz Kult; 2020; 97(1):25-34. PubMed ID: 32207705
[TBL] [Abstract][Full Text] [Related]
11. Neoadjuvant chemotherapy in patients with stages II and III breast cancer.
Yuan Z; Qu X; Zhang ZT; Wang Y
Chin Med J (Engl); 2009 Dec; 122(24):2993-7. PubMed ID: 20137489
[TBL] [Abstract][Full Text] [Related]
12. Neoadjuvant trastuzumab, pertuzumab, and chemotherapy versus trastuzumab emtansine plus pertuzumab in patients with HER2-positive breast cancer (KRISTINE): a randomised, open-label, multicentre, phase 3 trial.
Hurvitz SA; Martin M; Symmans WF; Jung KH; Huang CS; Thompson AM; Harbeck N; Valero V; Stroyakovskiy D; Wildiers H; Campone M; Boileau JF; Beckmann MW; Afenjar K; Fresco R; Helms HJ; Xu J; Lin YG; Sparano J; Slamon D
Lancet Oncol; 2018 Jan; 19(1):115-126. PubMed ID: 29175149
[TBL] [Abstract][Full Text] [Related]
13. Obesity is an independent prognostic factor of decreased pathological complete response to neoadjuvant chemotherapy in breast cancer patients.
Karatas F; Erdem GU; Sahin S; Aytekin A; Yuce D; Sever AR; Babacan T; Ates O; Ozisik Y; Altundag K
Breast; 2017 Apr; 32():237-244. PubMed ID: 27318645
[TBL] [Abstract][Full Text] [Related]
14. Neoadjuvant Pertuzumab-containing Regimens Improve Pathologic Complete Response Rates in Stage II to III HER-2/neu-positive Breast Cancer: A Retrospective, Single Institution Experience.
Murthy RK; Raghavendra AS; Hess KR; Fujii T; Lim B; Barcenas CH; Zhang H; Chavez-Mac-Gregor M; Mittendorf EA; Litton JK; Giordano SH; Thompson AM; Valero V; Moulder SL; Tripathy D; Ueno NT
Clin Breast Cancer; 2018 Dec; 18(6):e1283-e1288. PubMed ID: 30077429
[TBL] [Abstract][Full Text] [Related]
15. Effects of COVID-19 pandemic on breastfeeding rates in a neonatal intensive care unit.
Gunes AO; Dincer E; Karadag N; Topcuoglu S; Karatekin G
J Perinat Med; 2021 May; 49(4):500-505. PubMed ID: 33554582
[TBL] [Abstract][Full Text] [Related]
16. Validation of Residual Proliferative Cancer Burden as a Predictor of Long-Term Outcome Following Neoadjuvant Chemotherapy in Patients with Hormone Receptor-Positive/Human Epidermal Growth Receptor 2-Negative Breast Cancer.
Miglietta F; Dieci MV; Tsvetkova V; Griguolo G; Vernaci G; Menichetti A; Faggioni G; Giarratano T; Mioranza E; Genovesi E; Cumerlato E; Bottosso M; Saibene T; Michieletto S; Lo Mele M; Conte P; Guarneri V
Oncologist; 2020 Sep; 25(9):e1355-e1362. PubMed ID: 32618068
[TBL] [Abstract][Full Text] [Related]
17. [Role of clustered HER2/neu amplification as a marker for a special sensitivity to neoadjuvant anti-HER2 therapy with trastuzumab in patients with stage II-III breast cancer].
Kolyadina IV; Zavalishina LE; Ganshina IP; Andreeva YY; Frank GA; Gordeeva OO; Zhukova LG; Meshcheryakov AA; Savelov NA; Tuzova EA; Morozov DA; Poddubnaya IV
Arkh Patol; 2019; 81(6):56-62. PubMed ID: 31851193
[TBL] [Abstract][Full Text] [Related]
18. Serum Tumor Marker Levels might have Little Significance in Evaluating Neoadjuvant Treatment Response in Locally Advanced Breast Cancer.
Wang YJ; Huang XY; Mo M; Li JW; Jia XQ; Shao ZM; Shen ZZ; Wu J; Liu GY
Asian Pac J Cancer Prev; 2015; 16(11):4603-8. PubMed ID: 26107211
[TBL] [Abstract][Full Text] [Related]
19. Neoadjuvant chemotherapy and trastuzumab versus neoadjuvant chemotherapy followed by post-operative trastuzumab for patients with HER2-positive breast cancer.
Palmieri C; Macpherson IR; Yan K; Ades F; Riddle P; Ahmed R; Owadally W; Stanley B; Shah D; Gojis O; Januszewski A; Lewanski C; Asher R; Lythgoe D; de Azambuja E; Beresford M; Howell SJ
Oncotarget; 2016 Mar; 7(11):13209-20. PubMed ID: 26334099
[TBL] [Abstract][Full Text] [Related]
20. Complete Metabolic Response on Interim
Chen S; Ibrahim NK; Yan Y; Wong ST; Wang H; Wong FC
Oncologist; 2017 May; 22(5):526-534. PubMed ID: 28377466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
